QOL Outcomes Stable With Neurostimulation in Parkinson Disease
By Elana Gotkine HealthDay Reporter
MONDAY, Jan. 22, 2024 -- For patients with Parkinson disease (PD), differences in quality of life (QOL) outcomes are seen with deep brain stimulation of the subthalamic nucleus (STN-DBS), according to a study published online Jan. 18 in JAMA Network Open.
Stefanie T. Jost, Ph.D., from the University of Cologne in Germany, and colleagues examined the long-term effects of STN-DBS versus standard-of-care medication (MED) on QOL in a prospective observational, quasi-experimental trial involving patients with PD. Overall, 108 patients underwent propensity score-matching (62 in the STN-DBS group and 46 in the MED group), resulting in a well-balanced matched subcohort with 25 patients in each group.
The researchers found that Parkinson's Disease Questionnaire 8 (PDQ-8) and activities of daily living (ADL) worsened only in the MED group at five-year follow-up (PDQ-8 change, −10.9; ADL change, −2.0), while in the STN-DBS group, both outcomes remained stable. There was a moderate correlation observed for changes in PDQ-8 and ADL. STN-DBS outcomes were favorable for motor complications, mobility, and levodopa-equivalent daily dose reduction (mean differences in change scores between STN-DBS and MED, −2.0, −1.0, and −821.4, respectively).
"These findings may provide helpful information when counseling patients on the efficacy of STN-DBS for PD and monitoring patients postoperatively in long-term follow-up," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Excellent Outcomes Seen for Radiofrequency Catheter Ablation for Paroxysmal A-Fib
WEDNESDAY, May 22, 2024 -- Clinical outcomes are excellent with use of radiofrequency (RF) catheter ablation (CA) for paroxysmal atrial fibrillation (PAF), according to a study...
Volume of Leisure-Time Physical Activity Not Tied to Coronary Artery Calcium
WEDNESDAY, May 22, 2024 -- Ongoing leisure-time physical activity, even at high volumes, is not associated with coronary artery calcium (CAC) progression, a marker of...
Metastatic Cancer Survival No Better at Practices With Higher NQF 0210 Rates
WEDNESDAY, May 22, 2024 -- For patients with metastatic or advanced cancer, treatment at practices with higher rates of National Quality Forum (NQF) 0210 (patients receiving...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.